Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
International Ophthalmology
Erschienen in: International Ophthalmology 1/2024

01.12.2024 | Original Paper

Selective laser trabeculoplasty in the treatment of juvenile open angle glaucoma patients under 25 years of age

verfasst von: Ekrem Kurnaz

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Aim

To retrospectively evaluate the effectiveness and reliability of selective laser trabeculoplasty (SLT) treatment in juvenile open angle glaucoma (JOAG) cases.

Material and method

The 46 eyes of 28 cases that had undergone SLT for JOAG and had a follow-up of at least one month were included in the study. The pre-SLT, month 1, month 6, year 1, year 2, and final follow-up intraocular pressure (IOP); the number of drugs before and after the SLT procedure; and the complications caused by the SLT were recorded. An IOP below 21 mmHg without any additional medication or glaucoma surgery and an IOP decrease of 20% or more compared to the baseline were considered successful.

Results

There were 18 females and 10 males with a mean age of 17.52 ± 2.7 (13–22) years. The cases were followed-up for a mean duration of 39 (5–59) months. The mean IOP was 23.93 ± 0.52 mmHg before SLT and decreased to 17.15 ± 0.57 mmHg at month 1 after the procedure, 17.17 ± 0.52 mmHg at month 6, 18.02 ± 0.77 mmHg at year 1, 18.12 ± 0.48 mmHg at year 2, and 20.93 ± 0.69 mmHg at the final follow-up. The post-SLT IOP measurements at all times were found to be significantly lower than the pre-SLT values (p < 0.001). The mean number of drugs was 1.5 before the SLT and 0.59 afterwards (p < 0.001). The most common complications after SLT were anterior chamber inflammation in 29 cases (63.04%), hyperemia in 20 (43.40%) cases (4.34%), an early period IOP increase of 5 mmHg or more in 11 cases (23.91%), and mild ocular pain in 2 cases (4.34%).

Conclusion

SLT is an effective and reliable method for JOAG treatment.
Literatur
1.
European Glaucoma Society (2008) Terminology and guidelines for glaucoma, 3rd edn (2.2.1), p 95
2.
3.
Goldwyn R, Waltman SR, Becker B (1970) Primary open-angle glaucoma in adolescents and young adults. Arch Ophthalmol 84(5):579–582PubMedCrossRef
4.
Marshall LL, Hayslett RL, Stevens GA (2018) Therapy for open-angle glaucoma. Consult Pharm 33(8):432–445PubMedCrossRef
5.
Chardoub AAJ, Blair K (2022) Juvenile glaucoma. StatPearls Publishing
6.
Talbot AW, Russel-Eggit I (2000) Pharmaceutical management of the childhood glaucomas. Expert Opin Pharmacother 1(4):697–711PubMedCrossRef
7.
Wiggs JL, Del Bono EA, Schuman JS, Hutchinson BT, Walton DS (1995) Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-q31. Ophthalmology 102(12):1782–1789PubMedCrossRef
8.
Johnson AT, Drack AV, Kwitek AE, Cannon RL, Stone EM, Alward WL (1993) Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma. Ophthalmology 100(4):524–529PubMedCrossRef
9.
Ikeda H, Ishigooka H, Muto T, Tanihara H, Nagata M (2004) Long-term outcome of trabeculotomy for the treatment of developmental glaucoma. Arch Ophthalmol 122(8):1122–1128PubMedCrossRef
10.
Pathania D, Senthil S, Rao HL, Mandal AK, Garudadari CS (2014) Outcomes of trabeculectomy in juvenile open angle glaucoma. Indian J Ophthalmol 62(2):224–228PubMedPubMedCentralCrossRef
11.
Tsai JC, Chang HW, Kao CN, Lai IC, Teng MC (2003) Trabeculectomy with mitomycin C versus trabeculectomy alone for juvenile primary open-angle glaucoma. Ophthalmologica 217(1):24–30PubMedCrossRef
12.
Mark A, Latina MD, Joseph AJ, Tumbocon MD (2002) Selective laser trabeculoplasty: a new treatment option for open angle glaucoma. Curr Opinion Ophthalmol 13:94–96CrossRef
13.
Stangos AN, Whatham AR, Sunaric-Megevand G (2005) Primary viscocanalostomy for juvenile open-angle glaucoma. Am J Ophthalmol 140(3):490–496PubMedCrossRef
14.
Congdon N, Azuara-Blanco A, Solberg Y et al (2021) Direct selective laser trabeculoplasty in open angle glaucoma study design: a multicentre, randomised, controlled, investigator-masked trial (GLAUrious). Br J ophthalmol 0:1–4
15.
Agarwal HC, Sihota R, Das C, Dada T (2002) Role of argon laser trabeculoplasty as primary and secondary therapy in open angle glaucoma in Indian patients. Br J Ophthalmol 86:733–736PubMedPubMedCentralCrossRef
16.
Ansari E (2021) 10-year outcomes of first-line selective laser trabeculoplasty (SLT) for primary open-angle glaucoma (POAG). Graefe’s Arch Clin Exp Ophthalmol 259:1597–1604CrossRef
17.
Ticho U, Nesher R (1989) Laser trabeculoplasty in glaucoma: ten-year evaluation. Arch Ophthalmol 107:844–846PubMedCrossRef
18.
Investigators AGIS (2002) The advanced glaucoma intervention study (AGIS), 11: risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 134:481–498CrossRef
19.
The Glaucoma Laser Trial Research Group (1995) The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study, seven-year results. Am J Ophthalmol 120:718–731CrossRef
20.
Latina M, Park C (1995) Selective targeting of trabecular meshwork cells: in vitro studies of pulse and continuous laser interactions. Exp Eye Res 60:359–372PubMedCrossRef
21.
Kramer TR, Noecker RJ (2001) Comparison of the morphologic changes after selective laser trabeculoplasty in human eye bank eyes. Ophthalmology 108:773–779PubMedCrossRef
22.
Kun Hong B, Winer JC, Martone JF et al (2009) Repeat selective laser trabeculoplasty. J Glaucoma 18(3):180–183CrossRef
23.
Eyawo O, Lee C-W, Rachlis B et al (2008) Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature. Trials 9:69PubMedPubMedCentralCrossRef
24.
Latina MA, Sibayan SA, Shin DH et al (1998) Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 105:2082–2090PubMedCrossRef
25.
Woo DM, Healey PR, Graham SL (2015) Intraocular pressure-lowering medications and long term outcomes of selective laser trabeculoplasty: glaucoma laser and medical therapy. Clin Exp Ophthalmol 43:320–327PubMedCrossRef
26.
El Mallah MK, Walsh MM, Stinnett SS et al (2010) Selective laser trabeculoplasty reduces mean IOP and IOP variation in normal tension glaucoma patients. Clin Ophthalmol 4:889–893PubMedPubMedCentral
27.
Pan YI, Damji KF, Rock W et al (2004) Highly successful SLT is independent of glaucoma risk factors. Invest Ophthalmol Vis Sci 45:4456
28.
Hodge WG, Damji KF, Rock W et al (2005) Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol 89:1157–1160PubMedPubMedCentralCrossRef
29.
30.
Mills RP, Budenz DL, Lee PP et al (2006) Categorizing the stageof glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 141:24–30PubMedCrossRef
31.
Spaeth GL (1971) The normal development of the human anterior chamber angle: a new system of descriptive grading. Trans Ophthalmol Soc UK 91:709–739PubMed
32.
Leahy KE, White AJ (2015) Selective laser trabeculoplasty: current perspectives. Clin Ophthalmol 11:833–841
33.
Song J, Song A, Palmares T, Song M (2013) Selective laser trabeculoplasty success in pediatric patients with glaucoma: two case reports. J Med Case Rep 7:198PubMedPubMedCentralCrossRef
34.
Lui Y, Birt CM (2012) Argon versus selective laser trabeculoplasty in younger patients: 2-years results. J Glaucoma 21:112–115
35.
Gupta V, Ghosh S, Chaudhary S et al (2018) Selective laser trabeculoplasty for primary open-angle glaucoma patients younger than 40 years. Can J Ophthalmol 53(1):81–85PubMedCrossRef
36.
Lui D, Chen D, Tan Q et al (2020) Outcome of selective laser trabeculoplasty in young patients with primary open-angle glaucoma and ocular hypertension. J Ophthalmol 8:1–6
37.
Baser EF, Akbulut D (2015) Significant peripheral anterior synechiae after repeat selective laser trabeculoplasty. Can J Ophthalmol 50(3):36–38CrossRef
38.
Weinnand FS, Althen F (2006) Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol 16:100–104CrossRef
39.
Schlote T, Kynigopoulos M (2016) Selective laser trabeculoplasty: 1 year results in early and advanced open angle glaucoma. Int Ophthalmol 365:55–61CrossRef
40.
Francis BA, Ianchulev T, Schofield JK et al (2005) Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma. Am J Ophthalmol 140:524–525PubMedCrossRef
41.
Lee JW, Chan CV, Wong MO et al (2014) A randomized control trial to evaluate the effect of adjuvant selective laser trabeculoplasty versus medication alone in primary open-angle glaucoma: preliminary results. Clin Ophthalmol 8:1987–1992PubMedPubMedCentralCrossRef
42.
Lee R, Hutnik VML (2006) Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol 41:449–456PubMedCrossRef
43.
Wong MO, Lee JW, Choy BN et al (2015) Systemic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Surv Ophthalmol 60:36–50PubMedCrossRef
44.
45.
Rhodes KM, Weinstein R, Saltzmann RM et al (2009) Intra ocular pressure reduction in the untreated fellow eye after selective laser trabeculoplasty. Curr Med Res Opin 25:787–796PubMedCrossRef
46.
Kara N, Altınkaynak H, Şatana B et al (2011) Evaluation of factors influencing outcomes of selective laser trabeculoplasty in primary open angle glaucoma. Turk J Ophthalmol 41:304–308CrossRef
Metadaten
Titel
Selective laser trabeculoplasty in the treatment of juvenile open angle glaucoma patients under 25 years of age
verfasst von
Ekrem Kurnaz
Publikationsdatum
01.12.2024
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-024-03108-7

Weitere Artikel der Ausgabe 1/2024

International Ophthalmology 1/2024 Zur Ausgabe

Original Paper

Changes in ocular blood flow in patients with neovascular age-related macular degeneration after intravitreal injection of ranibizumab biosimilar and brolucizumab

Original Paper

Skeletal expansion via craniofacial distraction osteogenesis technique in syndromic craniosynostosis: impact on ophthalmic parameters

Original Paper

Assessment of the relationship between structural and functional tests in patients with idiopathic intracranial hypertension

Review

Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review

Original Paper

Ocular surface and meibomian gland evaluation in euthyroid Graves’ ophthalmopathy

Original Paper

An analysis of the factors involved in IOL decentration after phacoemulsification using CASIA 2 anterior segment optical coherence tomography

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen